{
    "2020-02-28": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Pharma Stock Roundup: FDA Updates From LLY, GSK, NVS, SNY to Spin-Off API Unit",
                "features": {
                    "keywords": [
                        "Pharma",
                        "FDA Updates",
                        "LLY",
                        "GSK",
                        "NVS",
                        "SNY",
                        "Spin-Off",
                        "API Unit"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-02-10",
                "original_text": "Biogen's Roller Coaster Continues In 2020 â€” Is BIIB Stock A Buy?",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Roller Coaster",
                        "BIIB",
                        "Stock",
                        "Buy"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}